Skip to main content

Day: October 7, 2021

Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors

NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has appointed Kevin Fitzgerald, Ph.D., to its Board of Directors. “We are very pleased to have Kevin join our Board of Directors. His experience transforming state-of-the-art science and novel platform technologies into commercial medicines will provide valuable perspective for Ovid’s neuroscience development programs,” said Jeremy Levin, D.Phil, MB BChir, Chairman and Chief Executive Officer of Ovid Therapeutics. “Kevin’s expertise across small molecule and next-generation modalities makes him an ideal director for Ovid as we pursue innovative platforms for the development and delivery of therapeutics...

Continue reading

International Land Alliance to Present at LD Micro Main Event on October 12, 2021

SAN DIEGO, CALIFORNIA, Oct. 07, 2021 (GLOBE NEWSWIRE) — International Land Alliance, Inc. (OTCQB:ILAL), (“ILA” or the “Company”), an international land investment and development firm, today announced that management will present at the LD Micro Main Event investor conference taking place October 12-14, 2021 virtually and in-person at the Luxe Sunset Bel Air in Los Angeles, California. Frank Ingrande, President of ILA, is scheduled to host a presentation during the conference as follows and will participate in one-on-one investor meetings throughout the day. LD Micro Main EventDate: Tuesday, October 12, 2021Time: 5:30 p.m. Eastern time (2:30 p.m. Pacific time) – Track 4Webcast: https://me21.mysequire.com/ A live audio webcast and archive of the event presentation will be available using the webcast link above. For more information...

Continue reading

WisdomTree Launches Target Range Fund (GTR)

Investment strategy seeking to balance risk and reward and address investor concerns over market volatility NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager, announced today the launch of the WisdomTree Target Range Fund (GTR) on NASDAQ with an expense ratio of 0.70%. GTR is an actively managed ETF that seeks to provide capital appreciation, with a secondary objective of hedging risk. In pursuing its investment objectives, GTR aims to follow the methodology of the TOPS® Global Equity Target RangeTM Index (the “Index”). The Index was created by Valmark Advisers, a subsidiary of Valmark Financial Group. “Investors face a complex market environment with elevated stock valuations and historically low...

Continue reading

Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference

WOBURN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will present at the Maxim Group Global AgTech Conference, which is being held virtually on October 14, 2021. The event will consist of four virtual panels with participation by executive management from multiple companies in the AgTech sector. Dr. Peoples will be presenting on the “Innovative Food Technologies” panel scheduled from 10:30 am to 11:50 am ET on October 14. The panel discussions will be moderated by Anthony Vendetti, Maxim’s Executive Director of Research & Senior Analyst. The keynote speaker will be Ambassador Kip E. Tom, the Chief Executive Officer of Leesburg-based Tom Farms, which grows corn, soybeans, and seed corn in seven...

Continue reading

Grom Social’s Top Draw Animation Studio Adds $1 Million in New Assignments

 Premium Supplier of Animation Production for Global Entertainment Brands Bolsters Output and Leverages New Leadership Team BOCA RATON, FL, Oct. 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grom Social Enterprises, Inc. (NASDAQ: GROM), today announced that its wholly-owned subsidiary, Top Draw Animation (TDA), has commenced production on approximately $1.0 million in new projects through its sprawling studio in Manila, the Philippines. The assignments, two recurring episodic animated TV series, bolster the studio’s output and leverage the expertise of Top Draw’s animation professionals as well as Russell Hicks and Jared Wolfson, the studio’s newly installed President and Executive Vice President, respectively. Due to confidentiality, Top Draw did not disclose either the series or the commissioning client. Recognized throughout...

Continue reading

Assure Holdings Leverages Relationships with Medical Device Distributors to Extend Reach in Texas

DENVER, Oct. 07, 2021 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), is pleased to announce that it has extended its reach within the state of Texas by leveraging medical device distributor referrals to initiate work with two new surgeons and expand the procedures it monitors at a Houston medical facility. “It is a priority for Assure to extend our footprint within states where we already operate to fully take advantage of our investment in these areas, drive profitability and capitalize on the economies of scale they represent,” said John A. Farlinger, Assure’s executive chairman and CEO. “We have been stepping up outreach to medical device distributors as part of our growth strategy. These new physician relationships...

Continue reading

Genasys Inc. Announces GEM Critical Communications Software Services Contracts in Five U.S. States

SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions, today announced that several counties and communities in Arkansas, Mississippi, Missouri, Pennsylvania and Texas have entered into multi-year Genasys Emergency Management (GEM) software services contracts. “GEM replaced incumbent emergency notification software systems in all but one of the contracted counties and communities,” said Richard S. Danforth, Chief Executive Officer, Genasys Inc. “Crisis situations are on the rise. Many areas are experiencing increasing risks from disasters, epidemics, civil unrest, active shooters and other perilous situations. Keeping residents and visitors safe through multi-channel alerting and real-time situational awareness is vital for public safety. “GEM’s...

Continue reading

Sensus Healthcare Announces Presentations, Demonstrations and Exhibit Booth at the 2021 Fall Clinical Conference in Las Vegas

Premier gathering expected to host more than 1,200 physicians with 500 virtual participants is the first in-person dermatology medical conference in 18 months Multiple tailwinds combine to support Sensus’ expectations for strong sales in 2H 2021 BOCA RATON, Fla., Oct. 07, 2021 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the company will be featuring its SRT-100 Vision™ system live at the 2021 Fall Clinical Conference being held in Las Vegas, Nev. from October 21 to 24.  More than 1,200 practitioners have already registered to attend this conference in person, while more than 500 are registered to participate virtually. In addition, key...

Continue reading

Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

Notice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036 NEWTON, Mass. and GENEVA, Oct. 07, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Acer’s patent application No. 17/196,416 for certain claims related to ACER-001 (sodium phenylbutyrate). The allowed patent claims in the application titled, “Palatable Compositions Including Sodium Phenylbutyrate and Uses Thereof,” include pharmaceutical composition claims covering ACER-001’s taste-masked, multi-particulate dosage formulation for oral administration. The USPTO issues a patent...

Continue reading

Phunware to Build New Headlines+ Website and Mobile Application Portfolio for Intermarkets

AUSTIN, Texas, Oct. 07, 2021 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced today that it will design, build and support the new Headlines+ website and mobile application portfolio for Intermarkets, Inc. Based just outside of Washington, DC and founded in 1997, Intermarkets connects publishers, advertisers and consumers through its portfolio of premium digital services. Intermarkets works closely with publishers to not only provide premium market representation and revenue opportunities, but also promote free speech across the internet. Intermarkets’ content aggregation service, Headlines+, will partner with independent content creators to curate and deliver top stories...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.